All News #Library
Rare Diseases
Satellos Unveils SAT-3247 Data In Duchenne Muscular Dystrophy
10 Mar 2026 //
GLOBENEWSWIRE
Satellos Hosts Virtual KOL Event on SAT-3247 for DMD
18 Feb 2026 //
BUSINESSWIRE
Satellos Doses First Patient in Phase 2 SAT-3247 DMD Study
12 Feb 2026 //
PHARMIWEB
Satellos Secures Clearance for SAT-3247 in DMD Phase 2 Trial
09 Dec 2025 //
PHARMIWEB
Satellos Joins Oppenheimer Rare Disease Summit
03 Dec 2024 //
BUSINESSWIRE
Satellos Receives Rare Pediatric Disease Designation For SAT-3247
08 Aug 2024 //
BUSINESSWIRE

Market Place
Sourcing Support